OTC · CANB
Can B Corp.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.02
Up+$0.00 (+16.18%)
Updated Aug 22, 2026, 5:37 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.25M
- P/E ratio
- -0.2
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 658.95K
- Avg. volume
- 105.37K
Price performance
CANB price history
1M range · 0 trading sessions · Daily adjusted prices
CANB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest CANB news
The latest Smart Investors Daily articles mentioning CANB.
Stock researchCompany · Overview
CANB research
Overview
Company profile and research snapshot.
Company profile
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 26, 2021 | Greenridge Global | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
